X-154428787-T-TGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGC
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_001183.6(ATP6AP1):c.116_117insGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGC(p.Ala41_Glu42insAlaAlaAlaAlaAlaAlaAlaAlaAlaAlaAla) variant causes a inframe insertion change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 21)
Consequence
ATP6AP1
NM_001183.6 inframe_insertion
NM_001183.6 inframe_insertion
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.146
Genes affected
ATP6AP1 (HGNC:868): (ATPase H+ transporting accessory protein 1) This gene encodes a component of a multisubunit enzyme that mediates acidification of eukaryotic intracellular organelles. Vacuolar ATPase (V-ATPase) is comprised of a cytosolic V1 (site of the ATP catalytic site) and a transmembrane V0 domain. V-ATPase dependent organelle acidification is necessary for such intracellular processes as protein sorting, zymogen activation, and receptor-mediated endocytosis. The encoded protein of this gene may assist in the V-ATPase-mediated acidification of neuroendocrine secretory granules. This protein may also play a role in early development. [provided by RefSeq, Aug 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP6AP1 | NM_001183.6 | c.116_117insGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGC | p.Ala41_Glu42insAlaAlaAlaAlaAlaAlaAlaAlaAlaAlaAla | inframe_insertion | 1/10 | ENST00000369762.7 | NP_001174.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP6AP1 | ENST00000369762.7 | c.116_117insGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGC | p.Ala41_Glu42insAlaAlaAlaAlaAlaAlaAlaAlaAlaAlaAla | inframe_insertion | 1/10 | 1 | NM_001183.6 | ENSP00000358777 | P1 |
Frequencies
GnomAD3 genomes Cov.: 21
GnomAD3 genomes
Cov.:
21
GnomAD4 exome Cov.: 31
GnomAD4 exome
Cov.:
31
GnomAD4 genome Cov.: 21
GnomAD4 genome
Cov.:
21
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 19, 2022 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. This variant has not been reported in the literature in individuals affected with ATP6AP1-related conditions. This variant is not present in population databases (gnomAD no frequency). This variant, c.116_117ins33, results in the insertion of 11 amino acid(s) of the ATP6AP1 protein (p.Ala41_Glu42ins11), but otherwise preserves the integrity of the reading frame. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.